Ophthalmogenetics and Gene Therapy

Gene therapy is moreover in a situation to manage essential open-edge glaucoma (POAG) in creature models, and research show it is monetarily reasonable. Genes may furthermore be conveyed into cells in vitro or in vivo making utilization of viral or non-viral vectors. Ongoing specialized advances have prompted the showing of the sub-atomic premise of a scope of visual sicknesses.

  • Genetics of Myopia Development
  • Gene Therapy
  • Usher syndrome
  • Familial exudative vitreal retinopathy
  • Retinoblastoma

Related Conference of Ophthalmogenetics and Gene Therapy

April 18 - 19, 2019

28th International Conference on Insights in Ophthalmology


Venue: Holiday Inn Rome Aurelia
July 05-06, 2019

Annual Ophthalmologists Meeting

Columbus, USA
July 29-30, 2019

18thAsia Pacific Ophthalmologists Annual Meeting

| Mercure Melbourne Albert Park | Melbourne, Australia
August 22-23, 2019

29th International Congress on VisionScience and Eye

Vienna | Austria
September 16-17, 2019

World Congress on Ophthalmology and Optometry

Singapore
October 28-29, 2019

20th Global Ophthalmologists Annual meeting

Amsterdam, Netherlands
Nov 14 - 15, 2019

33rd European Ophthalmology Congress

Madrid, Spain
December 5-6, 2019

3rd World Congress on Eye and Vision

Abu Dhabi, UAE
December 09-10, 2019

World Eye and Vision Congress

Abu Dhabi, UAE

Ophthalmogenetics and Gene Therapy Conference Speakers

Recommended Sessions

Related Journals

Are you interested in